Analysis of Pfizer's Investment Opportunity and Other Market Insights

Discussion on Pfizer's raised earnings forecasts, acquisition of C-Gen's cancer franchise, and its potential to lead in the oncology market despite regulatory concerns. The chapter also provides insight on investing in Pfizer and hints at future discussions on Adobe, energy, and pharmaceutical delivery companies.